Urofollitropin for Injection BP 75 IU

Urofollitropin for Injection BP 75 IU

Product Overview

Urofollitropin for Injection BP 75 IU is a prescription medication containing follicle-stimulating hormone (FSH). It is used in assisted reproductive therapies to support ovarian follicle development in women undergoing fertility treatments. It is administered under medical supervision as part of procedures such as in vitro fertilization (IVF) or intrauterine insemination (IUI).

How It Works

The active ingredient, urofollitropin, functions similarly to the body’s natural FSH. FSH is involved in the growth and maturation of ovarian follicles. When administered, it acts on ovarian receptors to support follicular development and estrogen production, which are associated with ovulation.

Uses / Indications

This is indicated for women with fertility conditions related to low or absent FSH activity, including certain types of anovulation or hypogonadotropic hypogonadism. It is also used in controlled ovarian stimulation protocols for assisted reproductive technologies such as IVF or IUI. Treatment should be initiated and monitored by a healthcare professional.

Composition

Each vial of Urofollitropin for Injection contains 75 IU of urofollitropin as the active ingredient. The medicine is supplied as a sterile injectable powder to be reconstituted with a solvent before use.

Administration

This medication is administered via subcutaneous or intramuscular injection. The dosage and treatment duration depend on clinical evaluation and patient response. Monitoring of hormone levels and follicle development may be required. Self-administration should only be done after training by a healthcare professional.

Storage Instructions

• Store in a refrigerator at 2°C to 8°C (36°F to 46°F)
• Do not freeze
• Protect from light and moisture
• Use the solution as directed after reconstitution
• Keep out of reach of children

Important Information

• Use only under medical supervision
• Possible risks include ovarian hyperstimulation, multiple pregnancy, and injection site reactions
• Report symptoms such as abdominal pain, rapid weight gain, or severe bloating to a healthcare professional
• Not suitable for certain conditions such as ovarian cysts unrelated to fertility treatment, unexplained vaginal bleeding, or hypersensitivity to gonadotropins

External Reference

For more information, refer to:
MedlinePlus – Fertility Medications